Skip to main content
Hereditary Cancer in Clinical Practice logoLink to Hereditary Cancer in Clinical Practice
. 2012 Jan 12;10(Suppl 1):A11. doi: 10.1186/1897-4287-10-S1-A11

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet

J Lubiński 1,, T Huzarski 1, A Jakubowska 1, J Gronwald 1, K Jaworska 1, M Muszyńska 1, G Sukiennicki 1, K Durda 1, C Cybulski 1, T Dębniak 1, A Tołoczko 1, O Oszurek 1, P Serrano-Fernandez 1, R Scott 1, S Narod 1
PMCID: PMC3287431

The aim of the study is to observe prospectively the possibility of lowering the cancer risk among BRCA1 carriers by optimizing selenium concentration in diet/organism. Results of studies performed in several centres, particularly of our own search, are strongly indicating on potential of decreasing breast/ovarian cancer risk among carriers by optimization of selenium concentration in the body. Studies will be performed on group of 1500 BRCA1 carriers. Cohort will be recruited during the first 6 months of the project. Mean length of follow-up will be 3 yrs. From all females serum will be collected for selenium analyses-at the beginning and, then, every 6 months. Participants will receive the list of products with selenium concentration estimated according to literature data and, additionally, information about e-store (http://www.dietaantyrakowa.pl) specialized in distribution of food products with defined amount of selenium. Information on optimal selenium concentration according to existing data will be provided also. It is expected that among ~750 carriers following recommended diet changes 38 cancers will be diagnosed and among the others ~750-60. The difference between groups will be statistically significant with p=0.0278. If necessary, investigation will be extended.


Articles from Hereditary Cancer in Clinical Practice are provided here courtesy of BMC

RESOURCES